Ethan Bier

This inventor holds 7 USPTO granted patents and 6 published patent applications. Top assignees: University of California, Scripps Research Institute. Active years: 2004-2021.

USPTO Granted Patents = 7 (Patent Applications = 6)

% Patents Active = 57.1

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

7 out of 15,977

University of California

patents

1 out of 1,204

Scripps Research Institute

patents

where one patent can have more than one assignee

Years Active: 2004-2021

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11091780 - Methods for autocatalytic genome editing and neutralizing autocatalytic genome editing and compositions thereof (2021-08-17),

2. 11083708 - Pharmacological restoration of epithelial or endothelial barrier integrity by agents blocking EPAC/RAP1 signaling (2021-08-10),

3. 9095579 - Protection and treatment against influenza infection (2015-08-04),

4. 7692059 - Method for generating overexpression of alleles in genes of unknown function (2010-04-06),

5. 7402566 - Peptide inhibitor of TGF-β growth factors (2008-07-22),

6. 7193126 - Method for generating overexpression of alleles in genes of unknown function (2007-03-20),

7. 6806358 - Peptide inhibitor of TGF-&bgr; growth factors (2004-10-19),

Title: Ethan Bier: Innovator in Genome Editing and Barrier Integrity Restoration

Introduction

Ethan Bier is a prominent inventor based in San Diego, CA (US), known for his groundbreaking work in the field of genome editing and pharmaceutical compositions. With a total of 7 patents, he has made significant contributions to the scientific community, particularly in the areas of genetic engineering and disease treatment.

Latest Patents

Ethan Bier's latest patents include innovative methods for autocatalytic genome editing and neutralizing autocatalytic genome editing. These patents describe methods and compositions that utilize the CRISPR/CAS9 system for genome editing in animals, humans, and plants. His work aims to eliminate pathogens, suppress crop pests, and combat diseases such as HIV and cancer by generating homozygous mutations that can be transmitted to nearly all offspring. Additionally, he has developed pharmacological methods for restoring epithelial or endothelial barrier integrity through agents that block EPAC/RAP1 signaling. These methods provide therapeutic options for patients suffering from diseases characterized by compromised barrier integrity.

Career Highlights

Ethan Bier has had a distinguished career, working with esteemed institutions such as the University of California and The Scripps Research Institute. His research has not only advanced the field of genome editing but has also opened new avenues for treating various diseases.

Collaborations

Throughout his career, Ethan has collaborated with notable colleagues, including Annabel Guichard and Kweon Yu. These partnerships have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Ethan Bier's contributions to genome editing and barrier integrity restoration highlight his role as a leading inventor in the scientific community. His innovative patents and collaborations continue to pave the way for advancements in medical and agricultural applications.